Stocksigma LogoStocksigma Logo

Bacil Pharma Subsidiary Signs ₹35 Crore R&D Agreement with Efdee Pharma

Bacil Pharma Limited announced that its wholly owned subsidiary, Bacil Research and Development Private Limited, entered into an R&D agreement with Efdee

Bacil Pharma Subsidiary Signs ₹35 Crore R&D Agreement with Efdee Pharma

Bacil Pharma Ltd · Others (Uncategorized) · 05 Nov 2026, 12:04 am

Bacil Pharma Subsidiary Signs ₹35 Crore R&D Agreement with Efdee Pharma Bacil Pharma Limited announced that its wholly owned subsidiary, Bacil Research and Development Private Limited, entered into an R&D agreement with Efdee Pharma Private Limited on 4th Nov'26. The project focuses on research and development activities for pharmaceutical products, covering pellets, granules, powders, tablets, and capsules. The total estimated cost of the project is ₹35.00 crore.

Original exchange filing (PDF)

More announcements from Bacil Pharma Ltd

All Bacil Pharma Ltd announcements